Join

Compare · HLN vs SLSN

HLN vs SLSN

Side-by-side comparison of Haleon plc (HLN) and Solesence Inc. (SLSN): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both HLN and SLSN operate in Package Goods/Cosmetics (Consumer Discretionary), so they compete in similar markets.
  • HLN is the larger of the two at $45.33B, about 685.9x SLSN ($66.1M).
  • HLN has been more active in the news (14 items in the past 4 weeks vs 6 for SLSN).
  • HLN has more recent analyst coverage (19 ratings vs 0 for SLSN).
MetricHLNSLSN
Company
Haleon plc
Solesence Inc.
Price
-
-
Market cap
$45.33B
$66.1M
1M return
-
-
1Y return
-
-
Sector
Consumer Discretionary
Consumer Discretionary
Industry
Package Goods/Cosmetics
Package Goods/Cosmetics
Exchange
NYSE
NASDAQ
IPO
2022
News (4w)
14
6
Recent ratings
19
0
HLN

Haleon plc

Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom. Haleon plc(LSE:HLN) operates independently of GSK plc as of July 18, 2022.

Latest HLN

Latest SLSN